Leda Notchey
Sales & Marketing chez Gen9, Inc.
Profil
Leda Notchey is currently the Vice President-Marketing at Gen9, Inc. Prior to her current position, she held the position of Senior Director-Marketing at Codon Devices, Inc. and was a Principal at Endogen, Inc., Revvity, Inc., and Dana-Farber Cancer Institute, Inc. Ms. Notchey received an undergraduate degree from the University of Massachusetts.
Postes actifs de Leda Notchey
| Sociétés | Poste | Début |
|---|---|---|
Gen9, Inc.
 Gen9, Inc. BiotechnologyHealth Technology Gen9, Inc. engages in the development of synthetic biology technologies. It transforms synthetic biology by creating technologies to increase innovation within several industries including biopharmaceuticals, fine chemicals and bio-fuels. The company was founded by Joseph M. Jacobson, George Church and Drew Endy in 2009 and is headquartered in Cambridge, MA. | Sales & Marketing | 20/10/2014 |
Anciens postes connus de Leda Notchey
| Sociétés | Poste | Fin |
|---|---|---|
Dana-Farber Cancer Institute, Inc.
 Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA. | Corporate Officer/Principal | - |
| REVVITY, INC. | Corporate Officer/Principal | - |
Endogen, Inc.
 Endogen, Inc. Medical SpecialtiesHealth Technology Part of Thermo Fisher Scientific, Inc., Endogen, Inc. is a company that specializes in producing reagents and immuno-assay test kits. The company is based in Cambridge, MA. Endogen was acquired by Perbio Science AB, part of Thermo Fisher Scientific, Inc. from September 24, 2003 on July 08, 1999 for $14.77 million. | Corporate Officer/Principal | - |
Codon Devices, Inc.
 Codon Devices, Inc. Pharmaceuticals: MajorHealth Technology Codon Devices, Inc. produces pharmaceuticals and biorefineries for the production of industrial chemicals and bio-energy. The firm designs and constructs biological components such as enzymes, biopharmaceuticals, and cell lines for improved function. Its customers include the biotechnology, pharmaceutical, and agriculture sectors. The company was founded by Noubar B. Afeyan, George Church, Drew Endy, Joseph M. Jacobson and Jay Keasling in 2004 and is headquartered in Cambridge, MA. | Sales & Marketing | - |
Formation de Leda Notchey
| University of Massachusetts | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| REVVITY, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Codon Devices, Inc.
Codon Devices, Inc. Pharmaceuticals: MajorHealth Technology Codon Devices, Inc. produces pharmaceuticals and biorefineries for the production of industrial chemicals and bio-energy. The firm designs and constructs biological components such as enzymes, biopharmaceuticals, and cell lines for improved function. Its customers include the biotechnology, pharmaceutical, and agriculture sectors. The company was founded by Noubar B. Afeyan, George Church, Drew Endy, Joseph M. Jacobson and Jay Keasling in 2004 and is headquartered in Cambridge, MA. | Health Technology |
Endogen, Inc.
Endogen, Inc. Medical SpecialtiesHealth Technology Part of Thermo Fisher Scientific, Inc., Endogen, Inc. is a company that specializes in producing reagents and immuno-assay test kits. The company is based in Cambridge, MA. Endogen was acquired by Perbio Science AB, part of Thermo Fisher Scientific, Inc. from September 24, 2003 on July 08, 1999 for $14.77 million. | Health Technology |
Dana-Farber Cancer Institute, Inc.
Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA. | Health Services |
Gen9, Inc.
Gen9, Inc. BiotechnologyHealth Technology Gen9, Inc. engages in the development of synthetic biology technologies. It transforms synthetic biology by creating technologies to increase innovation within several industries including biopharmaceuticals, fine chemicals and bio-fuels. The company was founded by Joseph M. Jacobson, George Church and Drew Endy in 2009 and is headquartered in Cambridge, MA. | Health Technology |